Amneal Pharmaceuticals
AMRX
#3551
Rank
โ‚น337.26 B
Marketcap
โ‚น1,073
Share price
-1.97%
Change (1 day)
43.76%
Change (1 year)

Revenue for Amneal Pharmaceuticals (AMRX)

Revenue in 2025 (TTM): โ‚น253.90 Billion

According to Amneal Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น263.71 Billion. In 2024 the company made a revenue of โ‚น239.68 Billion an increase over the revenue in the year 2023 that were of โ‚น199.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amneal Pharmaceuticals from 2018 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น253.90 B5.93%
2024 โ‚น239.68 B20.28%
2023 โ‚น199.26 B8.85%
2022 โ‚น183.06 B17.48%
2021 โ‚น155.83 B6.94%
2020 โ‚น145.72 B25.65%
2019 โ‚น115.97 B-0.26%
2018 โ‚น116.28 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.3 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น57.69 B-78.12%๐Ÿ‡บ๐Ÿ‡ธ USA